Literature DB >> 995142

Radioimmunoassay of myelin basic protein in spinal fluid. An index of active demyelination.

S R Cohen, R M Herndon, G M McKhann.   

Abstract

With a sensitive radioimmunoassay that can measure as little as 2 ng of basic protein in cerebrospinal fluid we studied 303 patients with a variety of neurologic diseases. Patients with active demyelinating diseases had high levels (17 to 100 ng per milliliter) of basic protein. Moreover, patients with multiple sclerosis in acute exacerbation had these high levels, those with slowly progressive multiple sclerosis had lower levels (6 to 16 ng per milliliter), and those in remission had less than 4 ng per milliliter, comparable to the control population. Thus, the assay appears to be a useful index of active demyelination.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 995142     DOI: 10.1056/NEJM197612232952604

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  29 in total

1.  Cerebrospinal fluid analysis differentiates between relapsing-remitting and secondary progressive multiple sclerosis.

Authors:  P J Jongen; K J Lamers; W H Doesburg; W A Lemmens; O R Hommes
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

2.  Developmental expression of autoimmune target antigens during organogenesis.

Authors:  T Akashi; Y Eishi
Journal:  Immunology       Date:  1991-11       Impact factor: 7.397

3.  Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome.

Authors:  R Crols; J Saerens; M Noppe; A Lowenthal
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 4.  Proteinases in inflammatory demyelinating disease.

Authors:  C T Bever; J N Whitaker
Journal:  Springer Semin Immunopathol       Date:  1985

5.  Dorsal column myelopathy after intrathecal chemotherapy for leukemia.

Authors:  Chelsea C Pinnix; Linda Chi; Elias J Jabbour; Sarah A Milgrom; Grace L Smith; Naval Daver; Naveen Garg; Matthew D Cykowski; Greg Fuller; David Cachia; Carlos Kamiya-Matsuoka; Karin Woodman; Courtney Dinardo; Nitin Jain; Tapan M Kadia; Naveen Pemmaraju; Maro Ohanian; Marina Konopleva; Hagop M Kantarjian; Bouthaina S Dabaja
Journal:  Am J Hematol       Date:  2017-02       Impact factor: 10.047

6.  Differences in interaction between immune complexes and complement receptors in serum and cerebrospinal fluid.

Authors:  M E Medof; J P Antel; J J Oger; G M Prince; B G Arnason
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

7.  Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.

Authors:  J H Carson; E Barbarese; P E Braun; T A McPherson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-04       Impact factor: 11.205

8.  An ultrastructural study of the cerebrospinal fluid in visna.

Authors:  G Georgsson; J R Martin; P A Pálsson; N Nathanson; E Benediktsdóttir; G Pétursson
Journal:  Acta Neuropathol       Date:  1979-10       Impact factor: 17.088

9.  Myelin basic protein in cerebrospinal fluid from children.

Authors:  A Kohlschütter
Journal:  Eur J Pediatr       Date:  1978-03-13       Impact factor: 3.183

10.  Anti-galactocerebroside antibodies in human cerebrospinal fluids determined by enzyme-linked immunosorbent assay (ELISA).

Authors:  T Ichioka; K Uobe; M Stoskopf; Y Kishimoto; G Tennekoon; W W Tourtellotte
Journal:  Neurochem Res       Date:  1988-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.